Sellas Life Sciences Stock Current Asset
| SLS Stock | USD 1.06 0.08 8.16% |
Sellas Life Sciences fundamentals help investors to digest information that contributes to Sellas Life's financial success or failures. It also enables traders to predict the movement of Sellas Stock. The fundamental analysis module provides a way to measure Sellas Life's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Sellas Life stock.
Total Current Assets is likely to drop to about 3.5 M in 2025. Non Current Assets Total is likely to drop to about 2.6 M in 2025. Sellas | Current Asset |
Sellas Life Sciences Company Current Asset Analysis
Sellas Life's Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
Sellas Current Asset Historical Pattern
Today, most investors in Sellas Life Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Sellas Life's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current asset growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Sellas Life current asset as a starting point in their analysis.
Sellas Life Current Asset |
| Timeline |
Current Asset is important to company's creditors and private equity firms as they will often be interested in how much that company has in current assets since these assets can be easily liquidated in case the company goes bankrupt. However, it is usually not enough to know if a company is in good shape just based on current asset alone; the amount of current liabilities should always be considered.
| Competition |
Sellas Total Assets
Total Assets |
|
In accordance with the recently published financial statements, Sellas Life Sciences has a Current Asset of 0.0. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The current asset for all United States stocks is 100.0% higher than that of the company.
Sellas Current Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Sellas Life's direct or indirect competition against its Current Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Sellas Life could also be used in its relative valuation, which is a method of valuing Sellas Life by comparing valuation metrics of similar companies.Sellas Life is currently under evaluation in current asset category among its peers.
Sellas Life Current Valuation Drivers
We derive many important indicators used in calculating different scores of Sellas Life from analyzing Sellas Life's financial statements. These drivers represent accounts that assess Sellas Life's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Sellas Life's important valuation drivers and their relationship over time.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Market Cap | 46.3M | 85.6M | 45.8M | 29.4M | 33.9M | 32.2M | |
| Enterprise Value | 12.0M | 65.1M | 29.6M | 27.8M | 32.0M | 62.6M |
Sellas Fundamentals
| Return On Equity | -8.88 | ||||
| Return On Asset | -1.29 | ||||
| Current Valuation | 48.72 M | ||||
| Shares Outstanding | 70.38 M | ||||
| Shares Owned By Insiders | 0.24 % | ||||
| Shares Owned By Institutions | 7.36 % | ||||
| Number Of Shares Shorted | 7.97 M | ||||
| Price To Book | 4.35 X | ||||
| Price To Sales | 26.90 X | ||||
| Gross Profit | 900 K | ||||
| EBITDA | 529 K | ||||
| Net Income | (37.34 M) | ||||
| Cash And Equivalents | 26.99 M | ||||
| Cash Per Share | 1.31 X | ||||
| Total Debt | 906 K | ||||
| Debt To Equity | 0.06 % | ||||
| Current Ratio | 2.36 X | ||||
| Book Value Per Share | (0.25) X | ||||
| Cash Flow From Operations | (31.41 M) | ||||
| Short Ratio | 14.07 X | ||||
| Earnings Per Share | (0.72) X | ||||
| Target Price | 5.83 | ||||
| Number Of Employees | 16 | ||||
| Beta | 2.4 | ||||
| Market Capitalization | 74.6 M | ||||
| Total Asset | 6.22 M | ||||
| Retained Earnings | (217.24 M) | ||||
| Working Capital | (10.56 M) | ||||
| Net Asset | 6.22 M |
About Sellas Life Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Sellas Life Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sellas Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sellas Life Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Sellas Stock Analysis
When running Sellas Life's price analysis, check to measure Sellas Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sellas Life is operating at the current time. Most of Sellas Life's value examination focuses on studying past and present price action to predict the probability of Sellas Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sellas Life's price. Additionally, you may evaluate how the addition of Sellas Life to your portfolios can decrease your overall portfolio volatility.